Literature DB >> 25837316

[Forms of age-related macular degeneration].

M Schargus1.   

Abstract

Age-related macular degeneration (AMD) is the major reason for blindness affecting about 50 % of blind people in Germany. Early forms of AMD with drusen and pigment epithelium changes can be detected in 20 % of patients over 65 years old. The dry form of AMD causes slow deterioration of visual acuity, which cannot currently be adequately treated. In contrast development of a choroidal neovascularization (CNV) membrane results in rapid visual loss which will become permanent if treatment is not started immediately. Using anti-vascular endothelial growth factor (VEGF) agents stabilization and improvement of visual acuity is possible. Special types of AMD, such as retinal angiomatous proliferation and polypoidal choroidal vasculopathy are much less common. The natural course of the diseases can be very different, end stages often result in scarring and anti-VEGF agents are only weakly effective.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25837316     DOI: 10.1007/s00347-014-3186-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  33 in total

1.  Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications.

Authors:  D Pauleikhoff; D Löffert; G Spital; M Radermacher; J Dohrmann; A Lommatzsch; A C Bird
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-06-25       Impact factor: 3.117

Review 2.  [Polypoidal choroidal vasculopathy].

Authors:  D A Märker; H Helbig; M A Gamulescu
Journal:  Klin Monbl Augenheilkd       Date:  2012-07-25       Impact factor: 0.700

3.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Pigment epithelial detachment in polypoidal choroidal vasculopathy.

Authors:  Akitaka Tsujikawa; Manabu Sasahara; Atsushi Otani; Norimoto Gotoh; Takanori Kameda; Daisuke Iwama; Yuko Yodoi; Hiroshi Tamura; Michiko Mandai; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2006-09-28       Impact factor: 5.258

6.  [Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE].

Authors:  B Lehmann; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

7.  Polypoidal choroidal vasculopathy in white patients.

Authors:  Stephen J Davis; Andreas K Lauer; Christina J Flaxel
Journal:  Retina       Date:  2014-11       Impact factor: 4.256

8.  Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.

Authors:  Gerald Seidel; Christoph Werner; Martin Weger; Iris Steinbrugger; Anton Haas
Journal:  Acta Ophthalmol       Date:  2013-06-21       Impact factor: 3.761

Review 9.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638

Review 10.  Age-related macular degeneration-clinical review and genetics update.

Authors:  R Ratnapriya; E Y Chew
Journal:  Clin Genet       Date:  2013-08       Impact factor: 4.438

View more
  1 in total

Review 1.  [Epidemiology of age-related macular degeneration].

Authors:  C Brandl; K J Stark; M Wintergerst; M Heinemann; I M Heid; R P Finger
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.